Drugs / SHP648
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04394286 | May 2020 → May 2021 | hemophilia B | Baxalta now part of Shire | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SHP648 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04394286 ↗ |
| Route | Intravenous | “single intravenous (IV) infusion of SHP648” NCT04394286 ↗ |